Prognostication in Lymph Node-Positive Prostate Cancer with No PSA Persistence After Radical Prostatectomy
-
Published:2024-02-14
Issue:6
Volume:31
Page:3872-3879
-
ISSN:1068-9265
-
Container-title:Annals of Surgical Oncology
-
language:en
-
Short-container-title:Ann Surg Oncol
Author:
Shiota MasakiORCID, Takamatsu Dai, Matsui Yoshiyuki, Yokomizo Akira, Morizane Shuichi, Saito Ryoichi, Miyake Makito, Tsutsumi Masakazu, Yamamoto Yoshiyuki, Tashiro Kojiro, Tomida Ryotaro, Narita Shintaro, Edamura Kohei, Yamaguchi Takahiro, Hashimoto Kohei, Kato Masashi, Kasahara Takashi, Yoshino Takayuki, Akamatsu Shusuke, Kaneko Tomoyuki, Matsukawa Akihiro, Matsumoto Ryuji, Joraku Akira, Saito Toshihiro, Kato Takuma, Kato Manabu, Enokida Hideki, Sakamoto Shinichi, Terada Naoki, Kanno Hidenori, Nishiyama Naotaka, Kimura Takahiro, Kitamura Hiroshi, Eto Masatoshi,
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Lestingi JFP, Guglielmetti GB, Trinh QD, Coelho RF, Pontes J Jr, Bastos DA, et al. Extended versus limited pelvic lymph node dissection during radical prostatectomy for intermediate- and high-risk prostate cancer: early oncological outcomes from a randomized phase 3 trial. Eur Urol. 2021;79:595–604. 2. Touijer KA, Sjoberg DD, Benfante N, Laudone VP, Ehdaie B, Eastham JA, et al. Limited versus extended pelvic lymph node dissection for prostate cancer: a randomized clinical trial. Eur Urol Oncol. 2021;4:532–9. 3. EAU guideline, Prostate cancer. Retrieved 30 Oct 2023 at https://uroweb.org/guidelines/prostate-cancer. 4. NCCN guidelines, Prostate cancer, version 4.2023. Retrieved 30 Oct 2023 at https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf. 5. Blas L, Shiota M, Nagakawa S, Tsukahara S, Matsumoto T, Monji K, et al. Validation of models predicting lymph node involvement probability in patients with prostate cancer. Int J Urol. 2022;29:428–34.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|